» Articles » PMID: 32203408

Young-onset Type 2 Diabetes Mellitus - Implications for Morbidity and Mortality

Overview
Specialty Endocrinology
Date 2020 Mar 24
PMID 32203408
Citations 171
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating data suggest that type 2 diabetes mellitus (T2DM) in younger people (aged <40 years), referred to as young-onset T2DM, has a more rapid deterioration of β-cell function than is seen in later-onset T2DM. Furthermore, individuals with young-onset T2DM seem to have a higher risk of complications than those with type 1 diabetes mellitus. As the number of younger adults with T2DM increases, young-onset T2DM is predicted to become a more frequent feature of the broader diabetes mellitus population in both developing and developed nations, particularly in certain ethnicities. However, the magnitude of excess risk of premature death and incident complications remains incompletely understood; likewise, the potential reasons for this excess risk are unclear. Here, we review the evidence pertaining to young-onset T2DM and its current and future burden of disease in terms of incidence and prevalence in both developed and developing nations. In addition, we highlight the associations of young-onset T2DM with premature mortality and morbidity.

Citing Articles

Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.

Lee H, Fernandes M, Lee J, Merino J, Kwak S Diabetologia. 2025; .

PMID: 40088285 DOI: 10.1007/s00125-025-06403-9.


Association between waist-to-hip ratio and testosterone in Chinese men with young-onset type 2 diabetes: a cross-sectional study.

Luo Y, Shao H, Zhang Q, Liu F, Zhang M, Zhang Y BMC Endocr Disord. 2025; 25(1):60.

PMID: 40050817 PMC: 11884136. DOI: 10.1186/s12902-025-01832-4.


Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.

Jiao Q, Huang Y, He J, Xu Y Pharmaceutics. 2025; 17(2).

PMID: 40006605 PMC: 11859201. DOI: 10.3390/pharmaceutics17020238.


Correlation Between Triglyceride-Glucose Index and Microvascular Complications in Patients With Early- Onset of Type 2 Diabetes Mellitus.

Ran L, Han Y, Zhaohu H, Hailin S Endocrinol Diabetes Metab. 2025; 8(2):e70027.

PMID: 39946246 PMC: 11824366. DOI: 10.1002/edm2.70027.


Brain Iron Deposition Alterations in Type 2 Diabetes Mellitus Patients With Mild Cognitive Impairment Based on Quantitative Susceptibility Mapping.

Zhao Q, Maimaitiaili S, Bi Y, Li M, Li X, Li Q J Diabetes. 2025; 17(1):e70052.

PMID: 39843980 PMC: 11753919. DOI: 10.1111/1753-0407.70052.


References
1.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

2.
Viner R, White B, Christie D . Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden. Lancet. 2017; 389(10085):2252-2260. DOI: 10.1016/S0140-6736(17)31371-5. View

3.
Savage P, BENNETT P, Senter R, Miller M . High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population. Diabetes. 1979; 28(10):937-42. DOI: 10.2337/diab.28.10.937. View

4.
Dean H, Moffatt M . Prevalence of diabetes mellitus among Indian children in Manitoba. Arctic Med Res. 1988; 47 Suppl 1:532-4. View

5.
Harding J, Pavkov M, Magliano D, Shaw J, Gregg E . Global trends in diabetes complications: a review of current evidence. Diabetologia. 2018; 62(1):3-16. DOI: 10.1007/s00125-018-4711-2. View